These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30399462)

  • 1. Ocular myasthenia gravis patients following the administration of tacrolimus and steroids.
    Omata T; Fukui K; Kodama K; Watanabe Y; Aoyama H; Fujii K; Shimojo N
    J Neurol Sci; 2019 Jan; 396():30-32. PubMed ID: 30399462
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual and systemic outcomes in pediatric ocular myasthenia gravis.
    Pineles SL; Avery RA; Moss HE; Finkel R; Blinman T; Kaiser L; Liu GT
    Am J Ophthalmol; 2010 Oct; 150(4):453-459.e3. PubMed ID: 20678749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with prednisolone and tacrolimus for myasthenia gravis with invasive thymoma.
    Miura S; Azuma K; Yamada K; Takamori S; Kawahara A; Noda K; Ayabe M; Kage M; Aizawa H; Taniwaki T
    Acta Neurol Belg; 2010 Mar; 110(1):107-9. PubMed ID: 20514937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A child with generalized myasthenia gravis successfully treated with tacrolimus].
    Goto T; Mori M; Yamagata T; Mizuguchi M; Momoi MY
    No To Hattatsu; 2007 Jul; 39(4):300-3. PubMed ID: 17633089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
    Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
    J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of a 2-year-old girl with intractable myasthenia gravis using tacrolimus.
    Kakisaka Y; Haginoya K; Yokoyama H; Ishitobi M; Wakusawa K; Sato I; Togashi N; Kitamura T; Fukuyo N; Yoshihara Y; Iinuma K
    Brain Dev; 2006 Sep; 28(8):534-6. PubMed ID: 16564661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of steroid-dependent myasthenia gravis patients with low-dose tacrolimus.
    Nagaishi A; Yukitake M; Kuroda Y
    Intern Med; 2008; 47(8):731-6. PubMed ID: 18421189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudo plus-minus lid syndrome.
    Bandini F
    Arch Neurol; 2009 May; 66(5):668-9. PubMed ID: 19433671
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis.
    Zach H; Cetin H; Hilger E; Paul A; Wuschitz B; Jung R; Auff E; Zimprich F
    Eur J Neurol; 2013 Apr; 20(4):708-13. PubMed ID: 23279780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ocular symptoms in myasthenia gravis.
    Bhanushali MJ; Wuu J; Benatar M
    Neurology; 2008 Oct; 71(17):1335-41. PubMed ID: 18936425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis.
    Wakata N; Saito T; Tanaka S; Hirano T; Oka K
    Clin Neurol Neurosurg; 2003 Dec; 106(1):5-8. PubMed ID: 14643908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of FK 506 for refractory eye symptoms in a young child with ocular myasthenia gravis.
    Ishigaki K; Shishikura K; Murakami T; Suzuki H; Hirayama Y; Osawa M
    Brain Dev; 2009 Sep; 31(8):634-7. PubMed ID: 18845408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis.
    Kim YH; Shin HY; Kim SM
    Yonsei Med J; 2019 Jul; 60(7):633-639. PubMed ID: 31250577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone.
    Shimojima Y; Matsuda M; Gono T; Ishii W; Tokuda T; Ikeda S
    J Clin Neurosci; 2006 Jan; 13(1):39-44. PubMed ID: 16307880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus monotherapy: a promising option for ocular myasthenia gravis.
    Yagi Y; Sanjo N; Yokota T; Mizusawa H
    Eur Neurol; 2013; 69(6):344-5. PubMed ID: 23549260
    [No Abstract]   [Full Text] [Related]  

  • 16. Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis.
    Minami N; Fujiki N; Doi S; Shima K; Niino M; Kikuchi S; Sasaki H
    J Neurol Sci; 2011 Jan; 300(1-2):59-62. PubMed ID: 21035148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.
    Shimojima Y; Gono T; Yamamoto K; Hoshi K; Matsuda M; Yoshida K; Ikeda S
    Clin Rheumatol; 2004 Jun; 23(3):262-5. PubMed ID: 15168159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
    Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of myasthenia gravis with tacrolimus.
    Evoli A; Di Schino C; Marsili F; Punzi C
    Muscle Nerve; 2002 Jan; 25(1):111-4. PubMed ID: 11754194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tacrolimus against Churg-Strauss syndrome in a patient with myasthenia gravis.
    Niiyama S; Amoh Y; Suzuki K; Wada T; Katsuoka K
    Rheumatol Int; 2010 Apr; 30(6):847-8. PubMed ID: 19582460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.